All results
3 results for tests
-
IMPACT; Phase I Study of IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult GBM
This is a phase I study to assess the safety and feasibility of IL-8 receptor modified patient-derived activated CD70 CAR T cell therapy in CD70+ adult…
- Ages
- 18 Years - 80 Years
- Sexes
- All
-
XTMab
A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis ### Inclusion Criteria: 1. Participant between 18 to 80 years (inclusive) of age. 2.…
- Ages
- 18 Years - 80 Years
- Sexes
- All
-
u-STOP LVAD Bleed
This is a Phase I, single ascending dose, first in human, open-label, non-controlled, dose-escalation trial that will investigate intravenous infusions of…
- Ages
- 18 Years - 80 Years
- Sexes
- All